Bio-Path Holdings, Inc.2023财年实现净利润-16.08百万美元，同比减少15.93%

自选股智能写手03-11

12月31日，Bio-Path Holdings, Inc.（BPTH.US）公布财报，公告显示公司2023财年净利润为-16.08百万美元，同比减少15.93%；其中营业收入为0.00美元，每股基本收益为-33.64美元。从资产负债表来看，Bio-Path Holdings, Inc.（BPTH.US）总负债2.78百万美元，其中短期债务103000.00美元，资产负债比为1.16，流动比率为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2418081495?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-11 00:17","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2418081495","market":"us","top_or_hot":-1,"title":"Bio-Path Holdings, Inc.2023财年实现净利润-16.08百万美元，同比减少15.93%","media":"自选股智能写手","content":"<div>\n<p>12月31日，Bio-Path Holdings, Inc.（BPTH.US）公布财报，公告显示公司2023财年净利润为-16.08百万美元，同比减少15.93%；其中营业收入为0.00美元，每股基本收益为-33.64美元。从资产负债表来看，Bio-Path Holdings, Inc.（BPTH.US）总负债2.78百万美元，其中短期债务103000.00美元，资产负债比为1.16，流动比率为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311001721876e4b2f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bio-Path Holdings, Inc.2023财年实现净利润-16.08百万美元，同比减少15.93%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBio-Path Holdings, Inc.2023财年实现净利润-16.08百万美元，同比减少15.93%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-11 00:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311001721876e4b2f&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>12月31日，Bio-Path Holdings, Inc.（BPTH.US）公布财报，公告显示公司2023财年净利润为-16.08百万美元，同比减少15.93%；其中营业收入为0.00美元，每股基本收益为-33.64美元。从资产负债表来看，Bio-Path Holdings, Inc.（BPTH.US）总负债2.78百万美元，其中短期债务103000.00美元，资产负债比为1.16，流动比率为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311001721876e4b2f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BPTH","symbol_name":"Bio-Path Holdings, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311001721876e4b2f&s=b","article_id":"2418081495","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311001721876e4b2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2418081495","pubTimestamp":1710087438,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"12月31日，Bio-Path Holdings, Inc.公布财报，公告显示公司2023财年净利润为-16.08百万美元，同比减少15.93%；其中营业收入为0.00美元，每股基本收益为-33.64美元。机构评级：截至2023年12月31日，当前有1家机构对Bio-Path Holdings, Inc.目标价做出预测，其中目标均价为240.00美元，其中最低目标价为240.00美元，最高目标价为240.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"BPTH":"Bio-Path Holdings, Inc."},"translate_title":"Bio-Path Holdings, Inc. achieved a net profit of-16. 08 million US dollars in fiscal year 2023, a year-on-year decrease of 15.93%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BPTH":1},"content_text":"12月31日，Bio-Path Holdings, Inc.（BPTH.US）公布财报，公告显示公司2023财年净利润为-16.08百万美元，同比减少15.93%；其中营业收入为0.00美元，每股基本收益为-33.64美元。从资产负债表来看，Bio-Path Holdings, Inc.（BPTH.US）总负债2.78百万美元，其中短期债务103000.00美元，资产负债比为1.16，流动比率为1.60。机构评级：截至2023年12月31日，当前有1家机构对Bio-Path Holdings, Inc.目标价做出预测，其中目标均价为240.00美元，其中最低目标价为240.00美元，最高目标价为240.00美元。公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。它致力于利用一种新技术，该技术可实现针对疾病中过度表达的任何基因产物的靶标特异性蛋白抑制的全身递送。 该公司的主要候选药物prexigebersen正处于急性髓性白血病（AML）2期临床试验的阶段，该试验结合低剂量阿糖胞苷（LDAC）和地西他滨联合使用。此外，该公司还有其他候选药物：BP1002和BP1003。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2418081495"}